KIR3DL2 参与成人急性 T 细胞白血病分型并是潜在治疗靶点
研究评估自然杀伤受体在成人 T 细胞白血病(ATL)中的表达,发现 KIR3DL2 在急性型 ATL 中高表达,与 HTLV-1 感染及启动子低甲基化相关,抗 KIR3DL2 抗体 lacutamab 可体外选择性杀伤 KIR3DL2+ 原代 ATL 细胞。
要点
- KIR3DL2 在急性型 ATL 中频繁表达,而在淋巴瘤型和慢性/冒烟型中少见。
- KIR3DL2 表达与启动子低甲基化相关,HTLV-1 感染可触发 CD4+ 细胞表达 KIR3DL2。
- lacutamab 在体外通过抗体依赖细胞毒作用选择性杀伤 KIR3DL2+ 原代 ATL 细胞。
核心结论
- KIR3DL2 表达与急性型 ATL 相关,其转录可能由 HTLV-1 感染触发并与启动子低甲基化相关,靶向 KIR3DL2 的获益正在一项随机 2 期研究中进一步探索。
研究设计与样本
- 发现队列纳入 21 例 ATL 评估自然杀伤受体表达,随后在 71 例 ATL 患者中评估 KIR3DL2。
- 通过靶向外显子测序比较急性型与淋巴瘤型 ATL 的突变谱,通过微阵列 DNA 甲基化分析确定 KIR3DL2 表达与启动子去甲基化的相关性。
- 采用 PrimeFlow RNA 检测原代 ATL 及体外 HTLV-1 感染的 CD4+ T 细胞中 KIR3DL2 与 TAX 信使 RNA 表达水平。
主要发现
- KIR3DL2 是所研究自然杀伤受体中唯一在急性型 ATL 中频繁表达者:急性型 40 例中 36 例、淋巴瘤型 16 例中 4 例、慢性/冒烟型 15 例中 1 例(P = .001)。
- 急性型与淋巴瘤型 ATL 的靶向外显子测序突变谱相似。
- TAX 信使 RNA 与 KIR3DL2 蛋白在 ATL 细胞上表达相关;HTLV-1 感染可触发 CD4+ 细胞表达 KIR3DL2,但单独 Tax 不诱导 KIR3DL2 表达。
- lacutamab 在体外通过自体抗体依赖细胞毒作用选择性杀伤 KIR3DL2+ 原代 ATL 细胞。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adult T-cell leukemia (ATL) is a lymphoid neoplasm caused by human T-cell leukemia virus type 1 (HTLV-1), which encodes the transcriptional activator Tax, which participates in the immortalization of infected T cells. ATL is classified into 4 subtypes: smoldering, chronic, acute, and lymphoma. We determined whether natural killer receptors (NKRs) were expressed in ATL. NKR expression (KIR2DL1/2DS1, KIR2DL2/2DL3/2DS2, KIR3DL2, NKG2A, NKG2C, and NKp46) was assessed in a discovery cohort of 21 ATL, and KIR3DL2 was then assessed in 71 patients with ATL. KIR3DL2 was the only NKR among those studied frequently expressed by acute-type vs lymphoma- and chronic/smoldering-type ATL (36 of 40, 4 of 16, and 1 of 15, respectively; P = .001), although acute- and lymphoma-type ATL had similar mutation profiles by targeted exome sequencing. The correlation of KIR3DL2 expression with promoter demethylation was determined by microarray-based DNA methylation profiling. To explore the role of HTLV-1, KIR3DL2 and TAX messenger RNA (mRNA) expression levels were assessed by PrimeFlow RNA in primary ATL and in CD4+ T cells infected with HTLV-1 in vitro. TAX mRNA and KIR3DL2 protein expressions were correlated on ATL cells. HTLV-1 infection triggered KIR3DL2 by CD4+ cells but Tax alone did not induce KIR3DL2 expression. Ex vivo, autologous, antibody-dependent cell cytotoxicity using lacutamab, a first-in-class anti-KIR3DL2 humanized antibody, selectively killed KIR3DL2+ primary ATL cells ex vivo. To conclude, KIR3DL2 expression is associated with acute-type ATL. Transcription of KIR3DL2 may be triggered by HTLV-1 infection and correlates with hypomethylation of the promoter. The benefit of targeting KIR3DL2 with lacutamab is being further explored in a randomized phase 2 study in peripheral T-cell lymphoma, including ATL (registered on https://clinicaltrials.gov as #NCT04984837).
引用
- Cheminant M, Lhermitte L, Bruneau J, et al. KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target. Blood. 2022. PMID: 35687761. doi:10.1182/blood.2022016765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。